SASHA SHUMPERT: Open Payments
NPI 1467959692 · COLUMBIA CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,875 in 122 payments from 21 companies in 2025. Trend: 2023 $1,126 · 2024 $1,677 · 2025 $1,875
Food & beverage: $1,875
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $321 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $183 |
| Lilly USA, LLC | 12 | $175 |
| Lundbeck LLC | 9 | $161 |
| Axsome Therapeutics, Inc. | 15 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $113 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| PFIZER INC. | 5 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
Products named: CAPLYTA, JARDIANCE, Auvelity, VRAYLAR, VYEPTI, TRINTELLIX, LINZESS, REXULTI.
Industry payments across IN — which companies pay providers there.
